2020 ISPE Continuous Manufacturing Virtual Workshop 

Thank You for Making this Virtual Conference a Huge Success!

The 2020 ISPE Continuous Manufacturing Virtual Workshop delivered engaging presentations and case studies on cutting-edge topics with many opportunities to gain insights from top industry professionals. Check out the content below to get insights from the conference.


10-Year Vision to Solve the Biggest Manufacturing Problems

Hear from keynote presenter John Erickson, PhD, Senior Fellow, NIIMBL | The National Institute for Innovation in Manufacturing Biopharmaceuticals, as he shares a 10-year vision to solve the biggest manufacturing problems during the session “A New Decade for Continuous Manufacturing” at the 2020 ISPE Continuous Manufacturing Virtual Workshop.


What Are Some Notable Process Contamination Risks in CM?

Cheryl Essex, Head of Microbiological Control for Biologic Drugs, Sanofi, addressed this during her presentation “Modern Microbiological Monitoring of Continuous Processing.” Watch now to get a snippet of her response during the 2020 ISPE Continuous Manufacturing Virtual Workshop.


Current Status on CM for Biologics: Development to Clinical Q&A

Hear from Jon Coffman, PhD, Senior Director of Bioprocess Technology and Engineering, AstraZeneca, and Mark Brower, Principal Scientist, Merck, as they answer questions at the end of the session "Current Status on CM for Biologics: Development to Clinical" at the 2020 ISPE Continuous Manufacturing Virtual Workshop.


Small Molecule Success Stories

Watch Now: Jeroen Geens, PhD, Engineering Technical Director, New Platforms, The Janssen Pharmaceutical Companies of Johnson & Johnson, gave attendees of the 2020 ISPE Continuous Manufacturing Virtual Workshop a look into Janssen’s CM-strategy during the session “Success Stories from Small Molecule Drug Product.”


What is next-generation manufacturing?

Watch Jon Coffman, PhD, Senior Director of Bioprocess Technology and Engineering, AstraZeneca, give his perspective during the session “Current Status on CM for Biologics: Development to Clinical” at the 2020 ISPE Continuous Manufacturing Virtual Workshop.


Conference Highlights


Program Committee

Christine M. V. Moore, PhD
Global Head and Executive Director, GRACS CMC Policy
Merck & Co, Inc.
Chair and Board Ambassador
Gabriella Dahlgren, PhD
Senior Manager, Strategy Deployment and Excellence, PQM
Janssen Supply Group LLC
Kelvin H. Lee, PhD
Director and Professor, Chemical & Biomolecular Engineering, Univ. of Delaware
NIIMBL
Michael K. O'Brien, PhD
Founder & President
NGT BioPharma Consultants
Jeffery N. Odum, CPIP
Head of Design, Technology & Standards, Biologics Engineering
Sanofi
Antonio R. Moreira, PhD
Vice Provost, Academic Affairs
University of Maryland, Baltimore County
Sharmista Chatterjee, PhD
Division Director
CDER, FDA
Malcolm B. Berry, PhD
Continuous Chemistry Team Manager
GlaxoSmithKline
Wyatt J. Roth, PhD
Senior Research Scientist
Eli Lilly & Co.
Placeholder Person Graphic
Matthew B. Shields
Head of Specialty Care Operations
Sanofi
Bernhardt L. Trout, Ph.D.
Professor, Chemical Engineering
MIT